GE HealthCare (Nasdaq: GEHC) announced today that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback